Showing results (341-350 of 566) with videos related to

Sort By:
Pageof 57
The New England Journal of Medicine|April 22, 2005
Leflunomide or methotrexate for juvenile rheumatoid arthritisEarl Silverman, Richard Mouy, Lynn Spiegel, et al.
RMD Open|July 21, 2022
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trialPhilip S Helliwell, Phillip J Mease, Arthur Kavanaugh, et al.
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
Rheumatology (Oxford, England)|July 14, 2023
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory goutHerbert S B Baraf, Puja P Khanna, Alan J Kivitz, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
RMD Open|February 5, 2019
Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL BeyondVibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, et al.
Lupus Science & Medicine|August 25, 2022
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)Rebecca Williams-Hall, Pamela Berry, Nicola Williamson, et al.
Lupus|November 1, 2021
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement studyLine Uhrenholt, Simone Høstgaard, Julie F Pedersen, et al.
Arthritis Care & Research|February 1, 2020
Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic ReviewMaria A Lopez-Olivo, Richard J Zogala, Jude des Bordes, et al.
Rheumatology and Therapy|December 7, 2020
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X TrialAtul Deodhar, Philip Mease, Proton Rahman, et al.
Pageof 57